Noxopharm Limited

A$0.04As of Sun 8 Nov 2026, 12:00 UTC
ASX:NOXHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (18.81%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.08
PE TTM —
TSR TTM (62.77%)
Mkt cap A$11.69M
ROIC (104.40%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0418
19.36%
(23.86%)
Hold 3|10|7|9|5
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
23.95%
30.12%
15.36%
21.14%
Revenue$M
0.812
0.841
0.821
0.807
15.53%
14.02%
5.58%
5.04%
Peers (US$8.031M)
Cap (US$)
PE
8.797M
—
7.761M
—
7.975M
—
Capital
TTM
5Y
10Y
Leveragex
1.634
0.060
0.051
EBIT/Intx
2.935
0.648
0.652
Own earn%
35.07
(11.88)
(7.70)
Sh yield%
48.83
20.10
18.83
Owners
Insiders/Inst%
11.53
75.15
Short interest%
4.25
SBC / revenue%
4.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
22–30
$1 testx
0.2
Incr. ROIC%
4